1
Advancements and Challenges in Multimodal Data Fusion for Bioinformatics AI

Priya Batta

Department of Computer Science and Engineering, Chandigarh University, Mohali, India

Abstract

An artificial intelligence technique used in bioinformatics integrates multiple biological data sources to understand complex biological processes. The research mainly focuses on the discovery of fusion technologies and their associated challenges. Despite the significant progress made in machine learning algorithms, various issues such as scalability, interpretability, and regulatory still exist. Drug discoveries, accurate medicine, and systems biology are the three main sectors of application. Future research should focus on increasing scalability, increasing interpretability, and promotion of data standardisation. Thus, it will make it easier to combine multimodal data in a more effective way, which will advance medical care and biological research.

Keywords: Artificial intelligence (AI), multimodal data fusion (MDF), bioinformatics, genomics, drug discovery

1.1 Introduction

There are many AI techniques which are used for combining various types of data from different biological sources; this is known as Multimodal data fusion (MDF) for AI [1]. Transcriptomics, proteomics, metabolomics, and medical data are only a few of the modalities that are used in this method to improve biological understanding, disease diagnosis, and appropriate therapy [2, 3].

Figure 1.1 Multimodal data fusion for bioinformatics AI.

In bioinformatics AI, MDF (as shown in Figure 1.1) is used as follows:

• Integration of Various Features: Various AI methods are implemented to combine features that have been gathered from multiple data modalities. In some cases, combining gene expression data with protein interaction networks or DNA sequences with clinical characteristics may provide a more detailed knowledge of biological processes [4].
• Neural Network Architectures: Deep Neural Networks (DNNs), Neural Networks with Recurrent Connections (RNNs), and Deep Belief Networks (DBNs) are a few machine learning models that can handle difficult multimodal data. Such architectures are capable of capturing intricate relationships between different kinds of data and using those connections to create their own representations [3, 5].
• Multimodal Embeddings: Automatic Encoders (AE) and Variational Automatic Encoders (VAEs) are two kinds of AI techniques employed for creating low-dimensional representations for multimodal feedback. These connections keep significant characteristics throughout modalities, which simplifies later tasks like classification, categorising, and regression [2, 6].
• Grid-based Fusion: Grid neural networks (GNNs) and other grid-based AI models are used for combining diverse biological networks. As these models include both node features and network topology, they can be helpful for exactly simulating connections within complicated biological systems, such as networks of gene regulation or protein-protein interaction networks [7].
• Transferable Learning: The method of transferring knowledge from one activity or data source to another is made easier by transfer learning methods. For particular bioinformatics applications, pre-trained AI models developed on huge data sets can be augmented by utilising knowledge from multiple sources and disciplines [8].
• Medical Decision Assistance: AI in bioinformatics has been applied to systems that help clinical decision-making through multimodal data integration. These systems can assist healthcare providers in identifying disorders, determining the best course of therapy, and predicting projections by combining healthcare data with genetic identification, imaging results, and other relevant data [9].
• Medicinal Development and Recycling: AI-driven MDF expedites these processes by merging biological structure, medical records, response profiles to medication, and cellular information. With this method, potentially novel drugs can be found, drug efficacy can be anticipated, and therapeutic benefits can be maximised [10].
• Medical Care: MDF enables personalised medical care by enabling methods that are based on the genetic profiles, medical features, and treatment outcomes of specific patients. Based on their analysis of multiple modalities, AI systems classify patients, estimate the possibility of disease, and propose specific therapies for every individual [8]. Essentially, multimodal data fusion in bioinformatics AI makes use of artificial intelligence capacity to combine different biological types of information and results in advancement in the discovery of drugs, medical care, and medical research.
• Usage of Genomics Data: Genomics technology is used to generate very large data sets containing different biological components, such as proteins, DNA, and chemicals. Multimodal data fusion approaches enable the integration of omics data from several platforms, providing a greater awareness of biological systems and functions [11, 12].
• Study of Biological Systems: MDF permits the development and analysis of biological networks, particularly genetic regulation systems, interaction between proteins networks, and biochemical networks. By combining various types of genomics data, researchers are able to determine complex connections and functional connections inside the biological systems [11, 13].
• Disease Biomarkers Recognition: Combining many genomic and imaging data sets enables researchers to identify valuable biomarkers and genetic fingerprints associated with diseases. This enables the development of individualised treatment plans and the early diagnosis of patient conditions [8, 14].

1.2 Literature Review

The state of MDF techniques has greatly advanced in the past few years. Deep Learning architectures have been used to improve traditional approaches such as Quantitative Fusion techniques [7, 10]. Combining data from various sources, including transcriptomics as well as these techniques, allows a more precise and deep knowledge of biological processes.

Various deep learning models [15] have shown remarkable capabilities in identifying various patterns from multimodal data. Graph-based fusion methods take advantage of the natural connections between biological components to model interactions, while ensemble learning techniques incorporate several models to improve the accuracy of predictions and standardisation.

Uses: MDF is used in various fields within bioinformatics AI. Personalised therapies are developed with the identification of disease subgroups and biomarkers in disease prognosis and diagnosis, which are made possible by the fusion of biological, transcriptomic, and imaging information. The creation of novel medicines is accelerated through the use of omics data integration in drug discovery, which makes target identification, drug repurposing, and drug response prediction easier [10]. Moreover, multimodal fusion is essential to precision medicine because it combines genetic profiles with patient-specific clinical data to customise therapy regimens and forecast treatment results. Reconstructing molecular pathways and regulatory mechanisms in systems biology allows for the integration of omics data with biological networks, revealing information on drug interactions and disease [13] processes.

Obstacles: Multimodal data fusion in bioinformatics AI has a number of obstacles in spite of its potential. Integrating heterogeneous data sources with different modalities, resolutions, and noise levels is a major problem. Maintaining compatibility and interoperability across various data types is still a crucial problem that calls for effective pre-processing and harmonisation methods [14].

Year-wise progress is shown as follows:

• 2018: The foundation for combining various data modalities in bioinformatics AI was established with the advent of fundamental fusion algorithms [5]. The restricted scalability of these strategies for huge datasets was one of the main obstacles faced, though.
• 2019: An important development was the use of machine learning for fusion activities. Nonetheless, problems with the models explainability and interpretability were apparent as significant holes.
• 2020: New potential for managing complicated biological data were presented by the development of graph-based fusion techniques. However, there were still issues in efficiently handling.
• 2021: Improving fusion performance through the use of ensemble learning approaches showed potential. Assessing the effectiveness of fusion models is still hampered by the absence of uniform evaluation metrics.
• 2022: While successfully merging temporal [11] and geographical data faced difficulties, the use of attention mechanisms in fusion algorithms was a noteworthy development.
• 2023: While fusion performance was enhanced by the incorporation of transfer learning techniques, permission and data privacy became more significant ethical problems.
• 2024: While new opportunities were created by the investigation of reinforcement learning in fusion tasks, interoperability between various data sources remained a major obstacle [4, 8].

Table 1.1 shows the year-wise progress of Multimodal data fusion in bioinformatics AI from 2018 to 2024 with methodology employed and gaps...